Future Planet Capital and UK Innovation Science and Seed Fund (UKI2S) are delighted to invite you to UKI2S’ EngBioX: Backing the DNA of success event on the 6th December 2023 between 5-7pm, The University Arms, Cambridge.
EngBioX will bring together some of the most innovative organisations in the engineering biology industry and discuss UKI2S’ expanded funding opportunities. It is a highly curated event, composed of handpicked companies and investors.
What to expect?
Hear from our Keynote: Will West, Chairman & CEO of CellCentric, presents “From foundation fundraising with UKI2S to late-stage trials: a journey to a major deal with Pfizer”
Engage with experienced panellists: Russ Tucker – Founder & CEO of Twig, Amanda Smith – CEO of Pencil, Ben Holland – Founder & CTO of Antiverse and Will West – Founder & CEO of CellCentric will be discussing funding.
Insight: Join next-generation gene-editing company Pencil, AI drug-discovery company Antiverse and industrial biotech Twig together with biotech CellCentric and explore biotech business models and fundraising journeys in our panel discussion featuring industry trailblazers.
Networking Opportunities: Connect with investors, partners, innovative start-ups and academics.
Funding Details: Discover our expanded engineering biology fund, supporting companies innovating in healthcare, food and renewables.
If you are interested in joining us, please RSVP by registering on Eventbrite here by the 02/12/23.